Mr Brandon Cheah

Autologous tumour-derived nanocarriers for precision drug delivery in glioblastoma

The barrier between our blood and the brain, which blocks anticancer drugs from entering, remains one of the main challenges in glioblastoma treatment. I am developing carriers derived from a patient’s own tumour cells to cross it and deliver drugs precisely.

Joined

2026

Supervisor

Dr Christos Tapeinos

Co-supervisors

Prof Petra Hamerlik

Funding

PhD by Enterprise Studentship